113 related articles for article (PubMed ID: 36426068)
21. The Role of Pharmacists in Managing Adverse Events Related to Immune Checkpoint Inhibitor Therapy.
Medina P; Jeffers KD; Trinh VA; Harvey RD
J Pharm Pract; 2020 Jun; 33(3):338-349. PubMed ID: 31694455
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life among Chinese patients with Crohn's disease: a cross-sectional survey using the EQ-5D-5L.
Gao Z; Wang P; Hong J; Yan Y; Tong T; Wu B; Hu J; Wang Z
Health Qual Life Outcomes; 2022 Apr; 20(1):62. PubMed ID: 35413910
[TBL] [Abstract][Full Text] [Related]
23. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
24. Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde MT; Niederer R; Wagner NB; Diem S; Berner F; Hasan Ali O; Hillmann D; Bergamin I; Joerger M; Risch M; Niederhauser C; Lenz TL; Früh M; Risch L; Semela D; Flatz L
J Cancer Res Clin Oncol; 2022 Mar; 148(3):647-656. PubMed ID: 34874490
[TBL] [Abstract][Full Text] [Related]
25. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
26. Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.
Dasgupta A; Tsay E; Federman N; Lechner MG; Su MA
Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35274131
[TBL] [Abstract][Full Text] [Related]
27. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
28. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
29. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
30. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
31. Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
Halle BR; Betof Warner A; Zaman FY; Haydon A; Bhave P; Dewan AK; Ye F; Irlmeier R; Mehta P; Kurtansky NR; Lacouture ME; Hassel JC; Choi JS; Sosman JA; Chandra S; Otto TS; Sullivan R; Mooradian MJ; Chen ST; Dimitriou F; Long G; Carlino M; Menzies A; Johnson DB; Rotemberg VM
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34635495
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China.
Wong ELY; Xu RH; Cheung AWL
BMJ Open; 2019 Sep; 9(9):e032544. PubMed ID: 31562165
[TBL] [Abstract][Full Text] [Related]
33. Neurological complications of immune checkpoint inhibitor cancer immunotherapy.
Zivelonghi C; Zekeridou A
J Neurol Sci; 2021 May; 424():117424. PubMed ID: 33812689
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
[TBL] [Abstract][Full Text] [Related]
35. Dermatological Autoimmune Considerations of Immune Checkpoint Therapy.
Fane LS; Efird JT; Jindal C; Biswas T
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289601
[TBL] [Abstract][Full Text] [Related]
36. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
[TBL] [Abstract][Full Text] [Related]
37. Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies.
Yu Y; Zhou Y; Zhang X; Tan K; Zheng J; Li J; Cui H
Front Oncol; 2022; 12():934093. PubMed ID: 35912183
[TBL] [Abstract][Full Text] [Related]
38. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S
Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774
[TBL] [Abstract][Full Text] [Related]
39. Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia.
Keaei M; Kuhlmann J; Conde R; Evers SM; Gonzalez J; Govers M; Hiligsmann M
Value Health Reg Issues; 2016 Dec; 11():68-72. PubMed ID: 27986201
[TBL] [Abstract][Full Text] [Related]
40. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis.
Cheung PWH; Wong CKH; Samartzis D; Luk KDK; Lam CLK; Cheung KMC; Cheung JPY
Scoliosis Spinal Disord; 2016; 11():19. PubMed ID: 27525314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]